JP2009530296A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530296A5
JP2009530296A5 JP2009500484A JP2009500484A JP2009530296A5 JP 2009530296 A5 JP2009530296 A5 JP 2009530296A5 JP 2009500484 A JP2009500484 A JP 2009500484A JP 2009500484 A JP2009500484 A JP 2009500484A JP 2009530296 A5 JP2009530296 A5 JP 2009530296A5
Authority
JP
Japan
Prior art keywords
phenyl
trifluoromethyl
pyrazolo
pyrimidin
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009500484A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009530296A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/006539 external-priority patent/WO2007109093A2/en
Publication of JP2009530296A publication Critical patent/JP2009530296A/ja
Publication of JP2009530296A5 publication Critical patent/JP2009530296A5/ja
Withdrawn legal-status Critical Current

Links

JP2009500484A 2006-03-17 2007-03-15 ピラゾロ[1,5−a]ピリミジン誘導体およびその使用方法 Withdrawn JP2009530296A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78363106P 2006-03-17 2006-03-17
PCT/US2007/006539 WO2007109093A2 (en) 2006-03-17 2007-03-15 Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2009530296A JP2009530296A (ja) 2009-08-27
JP2009530296A5 true JP2009530296A5 (https=) 2011-05-19

Family

ID=38522947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009500484A Withdrawn JP2009530296A (ja) 2006-03-17 2007-03-15 ピラゾロ[1,5−a]ピリミジン誘導体およびその使用方法

Country Status (9)

Country Link
US (1) US20070219186A1 (https=)
EP (1) EP1996594A2 (https=)
JP (1) JP2009530296A (https=)
CN (1) CN101405289A (https=)
AU (1) AU2007227557A1 (https=)
BR (1) BRPI0708813A2 (https=)
CA (1) CA2643968A1 (https=)
MX (1) MX2008011853A (https=)
WO (1) WO2007109093A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100029657A1 (en) * 2008-02-29 2010-02-04 Wyeth Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
WO2009108827A1 (en) * 2008-02-29 2009-09-03 Wyeth Fused tricyclic pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof
CN102223798A (zh) * 2008-09-24 2011-10-19 巴斯夫欧洲公司 用于防治无脊椎动物害虫的吡唑化合物
WO2010138820A2 (en) * 2009-05-28 2010-12-02 President And Fellows Of Harvard College N,n-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation
US9745320B2 (en) 2013-01-18 2017-08-29 Guangzhou Maxinovel Pharmaceuticals Co., Ltd. Five-and-six-membered heterocyclic compound, and preparation method, pharmaceutical composition and use thereof
US9242969B2 (en) * 2013-03-14 2016-01-26 Novartis Ag Biaryl amide compounds as kinase inhibitors
CR20190157A (es) 2016-08-31 2019-08-13 Agios Pharmaceuticals Inc Inhibidores de procesos metabólicos celulares
CN117659025A (zh) * 2017-10-30 2024-03-08 科罗拉多州立大学董事会法人团体 Toll样受体8(tlr8)特异性拮抗剂及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US5219857A (en) * 1986-10-16 1993-06-15 American Cyanamid Company Method of treating cognitive and related neural behavioral problems
US4847256A (en) * 1986-10-16 1989-07-11 American Cyanamid Company 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo(1,5-A)-pyrimidines
US5126340A (en) * 1986-10-16 1992-06-30 American Cyanamid Company 4-[(substituted)alkylcarbonyl]-4,5-dihydro and -4,5,6,7-tetrahydro-7-[(substituted)-phenyl]pyrazolo[1,5-a]pyrimidine-3-carbonitriles
US4963553A (en) * 1986-10-16 1990-10-16 American Cyanamid Co. 4-[(substituted) alkylcarbonyl]-4,5-dihydro- and -4,5,6,7-tetrahydro-7-[(substituted)phenyl]pyrazolo[1,5-a]pyrimidines
US5013737A (en) * 1988-02-22 1991-05-07 American Cyanamid Company 2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaphtylene-3,5-(4H)-diones and 2,4-8-trisubstituted-4,5-dihydro-5-thioxo-3H,6H-1,4,5A,8A-tetrazaacenaphthylen-3-ones
US4916137A (en) * 1988-02-22 1990-04-10 American Cyanamid Company 5-(Substituted-amino)-8-(phenyl or substituted-phenyl)-3H,6H-1,4,5A,8A-tetraazaacenaphthylen-3-ones and treatment of neural behavior disorders
US20070179161A1 (en) * 2003-03-31 2007-08-02 Vernalis (Cambridge) Limited. Pyrazolopyrimidine compounds and their use in medicine
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
WO2006033795A2 (en) * 2004-09-17 2006-03-30 Wyeth Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
WO2006033796A1 (en) * 2004-09-17 2006-03-30 Wyeth SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME
EP1736475A1 (en) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates

Similar Documents

Publication Publication Date Title
JP2009530296A5 (https=)
RU2487713C2 (ru) Фармацевтическая композиция и способ лечения или профилактики физиологических и/или патофизиологических состояний, ассоциированных с ингибированием киназ pi3k, у млекопитающих
JP2016523922A5 (https=)
NZ525334A (en) Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
JP2009519340A5 (https=)
US20100010008A1 (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
ES2543904T9 (es) Pirrolo[2,3-b]piridinas y pirrolo[2,3-b]pirimidinas sustituidas con heteroarilo como inhibidores de quinasas Janus
AU2014267220A1 (en) Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
SK1812002A3 (en) 3(5)-Amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
JP2010502716A5 (https=)
RU2004138787A (ru) Тиофенамидины, фармацевтическая композиция (варианты) и способ лечения симптомов нарушения, опосредованного каскадом реакций классического пути комплемента (варианты)
RU2008141510A (ru) Новые соединения
JP2009530296A (ja) ピラゾロ[1,5−a]ピリミジン誘導体およびその使用方法
RU2733406C2 (ru) МОДУЛЯТОРЫ ROR ГАММА (RORγ)
JP2017523223A5 (https=)
JP7643632B2 (ja) Kdm5阻害作用を有する3-アザビシクロ(3.1.0)ヘキサン誘導体およびその医薬用途
JP2008509955A5 (https=)
US20170015669A1 (en) Heteroarylamide inhibitors of tbk1
JP2019530708A5 (https=)
JP4908233B2 (ja) キナーゼ阻害剤として有用な1H−チエノ[2,3−c]ピラゾール誘導体
JP2007537255A5 (https=)
JP2006514940A5 (https=)
JPS6013764A (ja) (3―アミノ―1h―ピラゾール―4―イル)(ヘテロアリール)メタノン類
AU2004263278B2 (en) N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto
JP2017516772A5 (https=)